Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis

Abstract

BackgroundGastric cancer is one of the most common malignancies worldwide. Although the diagnosis and treatment of this disease have substantially improved in recent years, the five-year survival rate of gastric cancer is still low due to local recurrence and distant metastasis. An in-depth study of the molecular pathogenesis of gastric cancer and related prognostic markers will help improve the quality of life and prognosis of patients with this disease. The purpose of this study was to identify and verify key SNPs in genes with prognostic value for gastric cancer.MethodsSNP-related data from gastric cancer patients were obtained from The Cancer Genome Atlas (TCGA) database, and the functions and pathways of the mutated genes were analyzed using DAVID software. A protein-protein interaction (PPI) network was constructed using the STRING database and visualized by Cytoscape software, and molecular complex detection (MCODE) was used to screen the PPI network to extract important mutated genes. Ten hub genes were identified using cytoHubba, and the expression levels and the prognostic value of the central genes were determined by UALCAN and Kaplan-Meier Plotter. Finally, quantitative PCR and Western blotting were used to verify the expression of the hub genes in gastric cancer cells.ResultsFrom the database, 945 genes with mutations in more than 25 samples were identified. The PPI network had 360 nodes and 1616 edges. Finally, cytoHubba identified six key genes (TP53, HRAS, BRCA1, PIK3CA, AKT1, and SMARCA4), and their expression levels were closely related to the survival rate of gastric cancer patients.ConclusionOur results indicate that TP53, HRAS, BRCA1, PIK3CA, AKT1, and SMARCA4 may be key genes for the development and prognosis of gastric cancer. Our research provides an important bioinformatics foundation and related theoretical foundation for further exploring the molecular pathogenesis of gastric cancer and evaluating the prognosis of patients.

Exploring the prognostic significance of PKCε variants in cervical cancer

“…Single nucleotide polymorphisms (SNPs) are the most common form of genetic variants occurring in human [ 20 ]. SNPs in the coding sequence of genes might have deleterious effects on the structure and function of the protein that may lead to or contribute to oncogenesis [ 21 , 22 ]; as such, SNPs can be regarded as the genetic basis and as potential genetic markers for cancer susceptibility of an individual [ 23 ]. There are various SNPs identified in genes IL10, TP53, XRCC1, PAX8, CLPTM1L, HLA-A, and TGFBR2 which are associated with cervical carcinoma in different populations globally [ 4 , 24 , 25 ].…”

Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking

“…Approximately, in 50% GC cases TP53 (tumor protein p53) is mutated and is most commonly mutated gene in human cancers. This gene plays significant roles in cell cycle arrest, cellular senescence, apoptosis, differentiation and metabolism 47 . STAT3 acts as a carcinogen in GC, which can enhance the metastatic potential of tumor cells and promote the development and progression of tumors 48 .…”

MCM3AP-AS1: An Indispensable Cancer-Related LncRNA

“…Gastric cancer is the fifth most common malignancy and the second leading cause of cancer-related mortality worldwide (Liu et al, 2016;Seidlitz et al, 2019;Kang et al, 2020;Harada et al, 2021;Li et al, 2021). Cisplatin (CDDP) is a well-known chemotherapeutic agent used to treat gastric cancer (Germann et al, 2002;Ivanova et al, 2013;Huang et al, 2019).…”